RE:RE:RE:RE:Up,Up and let's hope away up.Sounds like Bob, has been telliing quite a few people things, clearly they are not true and do not materialize... Heres the deal I have been saying this for two years, their wont be any licensing deals or cash coming. I think this was easily doable over the last couple of years, but would have cut into the insider filings and pp's by Interinvest...Think about it when the comany started they had a research agreement with Biogen in the first year for Cash from Biogen and Amorfix shares.. If Gundel is only sitting with 5,370 shares as reported in the last couple of proxies we are all in trouble. The anwer lies in Bermuda with what he really has and other insiders. The company has re-cyled old news, slipped out news very quitely under the radar screen in an untimely manner, all to keep the stock where it is will the insiders accumulate more, re-cyling old exuses. Call a spade a spade and take off the rose colored glasses...
Now for some news: Available under Googel Patent Search... Antibodies and Conjugates targeting a misfolded Prion Protein... You need to change language from French to English ...tried to hide another one.
Filed June 11, 2013
Published Dec 19,2013
Applicants: Amorfix Life Sciences, Helix Biopharma Corp.
Abstract: The misfolded form of Human Prp is Associated with various disease states. The present invention provides an antibody to detect and treat Useful such diseases including Cancer, such as Ovarian Cancer and Lymphomas, andTransmissible Spongiform Encephalopagthies: such as CJD. Also provided is an Immunoconjucate. In all which the Antibody is conjugated with Urease as Cytoxin.
The Description part of the patent also describes an Antibody to detect and treat Useful such Diseases , including Cancer, such as Ovarion cancer and Lyphomas, and Transmissible Spongiform encephalopathies; such as CJD